7-Eleven/Speedway: Bumps on the Road to Closing: Are Conventional Closing Conditions Sufficient to Protect Buyer Interests? | Cadwalader, Wickersham & Taft LLP jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
ADVERTISEMENT
7-Eleven Sparks FTC Uproar With Close Of Speedway Deal
Law360 (May 14, 2021, 10:10 PM EDT) 7-Eleven Inc. s decision Friday to wrap its $21 billion purchase of Speedway while the FTC merger review is still underway was assailed by the Federal Trade Commission s two Democrats, but also highlighted the ideological tensions created by the panel s even split along party lines.
In criticizing the convenience store giant s decision to close the deal while the FTC s investigation remains open, acting Chairwoman Rebecca Kelly Slaughter and Commissioner Rohit Chopra, the panel s two Democrats, warned in a statement Friday that there was a strong likelihood the deal could be blocked. In a rival statement, however, Republican commissioners Noah Joshua Phillips and Christine.
Advertisement
International Coalition of Competition Enforcement Agencies Seek Public Comment to Explore “New or Refreshed” Theories of Competitive Harm Related to Pharmaceutical Mergers Thursday, May 13, 2021
On Tuesday, May 11, 2021, an international coalition of competition enforcement agencies including the Federal Trade Commission, the U.S. Department of Justice’s Antitrust Division, Offices of State Attorneys General, Canada’s Competition Bureau, the European Commission Directorate General for Competition, and the U.K.’s Competition and Markets Authority issued a notice seeking public input to inform their approaches to analyzing the competitive effects of pharmaceutical mergers.
In March 2021, the agencies announced that they formed the Multilateral Pharmaceutical Merger Task Force (“Task Force”) to identify steps to review and update their analysis of pharmaceutical mergers. The Task Force seeks to explore “new or refreshed” theories of h
To embed, copy and paste the code into your website or blog:
On Tuesday, May 11, 2021, an international coalition of competition enforcement agencies including the Federal Trade Commission, the U.S. Department of Justice’s Antitrust Division, Offices of State Attorneys General, Canada’s Competition Bureau, the European Commission Directorate General for Competition, and the U.K.’s Competition and Markets Authority issued a notice seeking public input to inform their approaches to analyzing the competitive effects of pharmaceutical mergers.
In March 2021, the agencies announced that they formed the Multilateral Pharmaceutical Merger Task Force (“Task Force”) to identify steps to review and update their analysis of pharmaceutical mergers. The Task Force seeks to explore “new or refreshed” theories of harm to address anticompetitive effects from pharmaceutical mergers, acquisitions, joint ventures, and consolidation. Specifically, the Task Force will review what
The State of Oklahoma, joined by the U.S. Trotting Association, Hanover Shoe Farms, the State of West Virginia and others, filed a federal lawsuit in the Eastern Division of Kentucky U.S. District Court challenging the constitutionality of the Horseracing Integrity and Safety Act on Monday (April 26).
Other plaintiffs in the complaint filed for a declaratory judgment and injunctive relief are the Oklahoma Horse Racing Commission, West Virginia Racing Commission, Oklahoma Quarter Horse Racing Association and three Oklahoma racetracks – Remington Park, Will Rogers Downs and Fair Meadows.
“The U.S. Trotting Association has been pressing these unconstitutionality objections for more than four years and we have been ignored,” said USTA President and Hanover Shoe Farms President & CEO Russell Williams. “Instead, Senator McConnell sneaked HISA through at the last minute, without any hearing or debate, in the middle of a 5,500-page, must-pass omnibus funding measure.